Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
| $1.65M | ﹤0.01% |
24,337
-115,790
| -83% | -$7.45M |
|
2952
Pediatrix Medical
MD
$2.18B
| $1.65M | ﹤0.01% |
142,087
+106,817
| +303% | +$1.01M |
|
2953
First Financial Corp
THFF
$958M
| $1.64M | ﹤0.01% |
37,457
+14,349
| +62% | +$610K |
|
2954
PUT
Peloton Interactive
PTON
$2.77B
| $1.64M | ﹤0.01% |
+350,000
| New | +$1.38M |
|
2955
PUT
Trump Media & Technology Group
DJT
$2.73B
| $1.64M | ﹤0.01% |
+101,800
| New | +$2.47M |
|
2956
CALL
Vale
VALE
$64.1B
| $1.64M | ﹤0.01% |
140,000
| – | – |
|
|
VZIO
2957
DELISTED
VIZIO Holding Corp.
VZIO
| $1.63M | ﹤0.01% |
146,307
+113,518
| +346% | +$1.26M |
|
2958
Shoals Technologies Group
SHLS
$1.47B
| $1.63M | ﹤0.01% |
291,242
+226,556
| +350% | +$1.35M |
|
2959
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $1.63M | ﹤0.01% |
30,899
-10,985
| -26% | -$559K |
|
2960
Healthcare Services Group
HCSG
$1.6B
| $1.63M | ﹤0.01% |
145,926
+91,733
| +169% | +$1.01M |
|
2961
Colliers International
CIGI
$5.04B
| $1.63M | ﹤0.01% |
+10,734
| New | +$1.46M |
|
2962
First Advantage
FA
$3.4B
| $1.62M | ﹤0.01% |
81,669
+29,752
| +57% | +$531K |
|
2963
GDS Holdings
GDS
$6.56B
| $1.62M | ﹤0.01% |
79,376
-144,586
| -65% | -$2.04M |
|
2964
ARS Pharmaceuticals
SPRY
$509M
| $1.62M | ﹤0.01% |
111,666
+73,127
| +190% | +$870K |
|
|
THR
2965
DELISTED
Thermon Group Holdings
THR
| $1.62M | ﹤0.01% |
54,149
+41,009
| +312% | +$1.24M |
|
2966
Kiniksa Pharmaceuticals
KNSA
$5.8B
| $1.62M | ﹤0.01% |
64,629
+29,790
| +86% | +$726K |
|
2967
BioLife Solutions
BLFS
$1.53B
| $1.61M | ﹤0.01% |
64,423
+10,803
| +20% | +$255K |
|
|
PWSC
2968
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $1.61M | ﹤0.01% |
70,702
+46,151
| +188% | +$1.04M |
|
2969
Standard Motor Products
SMP
$851M
| $1.61M | ﹤0.01% |
48,522
+37,971
| +360% | +$1.19M |
|
|
SEMR
2970
DELISTED
Semrush
SEMR
| $1.61M | ﹤0.01% |
102,407
+54,830
| +115% | +$766K |
|
2971
Aurinia Pharmaceuticals
AUPH
$1.91B
| $1.61M | ﹤0.01% |
219,331
+143,072
| +188% | +$887K |
|
2972
AMERISAFE
AMSF
$543M
| $1.61M | ﹤0.01% |
33,219
+26,084
| +366% | +$1.24M |
|
2973
PUT
Energy Transfer Partners
ET
$70.1B
| $1.6M | ﹤0.01% |
+100,000
| New | +$1.61M |
|
2974
Heritage Financial
HFWA
$1.22B
| $1.6M | ﹤0.01% |
73,300
+37,606
| +105% | +$802K |
|
2975
Prothena Corp
PRTA
$425M
| $1.59M | ﹤0.01% |
95,222
+49,916
| +110% | +$1.07M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.